BioNTech SE (BNTX)
95.18
-0.67
(-0.70%)
USD |
NASDAQ |
Dec 10, 14:15
BioNTech EPS Diluted (Quarterly): -0.1395 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| CureVac NV | 1.414 |
| Novavax, Inc. | -1.246 |
| Pfizer Inc. | 0.6197 |
| Bristol Myers Squibb Co. | 1.079 |
| Moderna, Inc. | -0.5128 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -33.54M |
| Revenue (Quarterly) | 1.775B |
| Total Expenses (Quarterly) | 1.808B |
| Enterprise Value | 6.442B |
| Gross Profit Margin (Quarterly) | 90.24% |
| Profit Margin (Quarterly) | -1.89% |
| Earnings Yield | -2.76% |
| Normalized Earnings Yield | -3.182 |